Drug
Vch 759
Vch 759: highest development phase Phase 1/2, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VCH-759 (BCH-27759) NCT00389298 | Phase 1/2 | Hepatitis C, Chronic |
Latest
No recent events.
Follow Vch 759 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.